Health Trials

ANCA-Associated Glomerulonephritis

2

Review clinical trials related to ANCA-Associated Glomerulonephritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

An Exploratory, Single-Arm, Open-Label, Dose-Escalation Study of the Safety, Tolerability, PK, PD, and Efficacy of Anti-CD19/BCMA Universal CAR-T Therapy RD06-05 in Autoimmune Diseases (including SLE/LN, AAV/AAGN, Anti-GBM, MN, SSc, and IIM).

Participants needed: 84
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Nanjing Bioheng Biotech Co., Ltd.Updated: Oct 2, 2025Locations: 1
Eligibility criteria

Willing and able to provide written informed consent. [+21]

Severe active central nervous system (CNS) lupus, including psychosis, seizures,... [+11]

Read more
Status: Not yet recruiting

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

This study will evaluate the safety and efficacy of MSC303 in patients with Immune glomerular diseases.

Participants needed: 12
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Shanghai Changzheng HospitalUpdated: Jun 11, 2025Locations: 1
Eligibility criteria

Aged 18 to 65 years (including boundary values), gender unspecified； [+4]

History of severe allergic reaction to humanized monoclonal antibodies, or known... [+5]

Read more